Whistleblower Suits May Win Broad Endorsement From Supreme Court

During oral arguments, justices appear wary of blocking suits based on state data, but pharma says allowing them could create a cottage industry of individuals filing tenuous allegations.

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet